1146 Self-assembly neoantigen peptides for personalized cancer vaccines

1146 Self-assembly neoantigen peptides for personalized cancer vaccines

Bibliographic Details
Main Authors:	Yu Zhao, Andrew Wang
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

The perfect personalized cancer therapy: cancer vaccines against neoantigens
by: Luigi Aurisicchio, et al.
Published: (2018-04-01)

Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer
by: Zhenyu Ding, et al.
Published: (2021-01-01)

Automated Flow Synthesis of Tumor Neoantigen Peptides for Personalized Immunotherapy
by: Truex, Nicholas, et al.
Published: (2020)

Epidemiology of middle ear and mastoid cholesteatomas: study of 1146 cases Epidemiologia do colesteatoma da orelha média e mastoide: estudo de 1146 casos
by: Jose Evandro Andrade Prudente de Aquino, et al.
Published: (2011-06-01)

Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer
by: Brandon Mistretta, et al.
Published: (2023-09-01)

Identification and Targeting of Mutant Peptide Neoantigens in Cancer Immunotherapy
by: Daniel J. Verdon, et al.
Published: (2021-08-01)

A Neoantigen-Based Peptide Vaccine for Patients With Advanced Pancreatic Cancer Refractory to Standard Treatment
by: Zheling Chen, et al.
Published: (2021-08-01)

Personalized Neoantigen-Pulsed DC Vaccines: Advances in Clinical Applications
by: Lin Tang, et al.
Published: (2021-07-01)

Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy
by: Jiawei Shou, et al.
Published: (2022-09-01)

Current Trends in Neoantigen-Based Cancer Vaccines
by: Szu-Ying Ho, et al.
Published: (2023-03-01)

Designing neoantigen cancer vaccines, trials, and outcomes
by: Nupur Biswas, et al.
Published: (2023-02-01)

Comparison of personal and shared frameshift neoantigen vaccines in a mouse mammary cancer model
by: Milene Peterson, et al.
Published: (2020-05-01)

Nanomaterial Delivery Vehicles for the Development of Neoantigen Tumor Vaccines for Personalized Treatment
by: Xiaoyu Huang, et al.
Published: (2024-03-01)

Spleen‐targeted neoantigen DNA vaccine for personalized immunotherapy of hepatocellular carcinoma
by: Ming Wu, et al.
Published: (2023-10-01)

Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design
by: Iker Malaina, et al.
Published: (2023-05-01)

Adjuvant Treatment for Breast Cancer Patients Using Individualized Neoantigen Peptide Vaccination—A Retrospective Observation
by: Henning Zelba, et al.
Published: (2022-11-01)

The Development of Tumor Neoantigen Vaccine Immunotherapy
by: Wang Wanqiu
Published: (2019-01-01)

Circular RNA as a source of neoantigens for cancer vaccines
by: Yi Ren, et al.
Published: (2024-03-01)

Neoantigen cancer vaccines: a new star on the horizon
by: Xiaoling Li, et al.
Published: (2024-04-01)

Neoantigen-based therapeutic cancer vaccine: Towards a bright future
by: Yuning Wang, et al.
Published: (2024-01-01)

Targeting neoantigens for cancer immunotherapy
by: Xuan Zhao, et al.
Published: (2021-07-01)

Genome analysis of environmental and clinical P. aeruginosa isolates from sequence type-1146.
by: David Sánchez, et al.
Published: (2014-01-01)

289 PGV-001: a phase 1 trial of a personalized neoantigen peptide vaccine for the treatment of malignancies in the adjuvant setting
by: Nina Bhardwaj, et al.
Published: (2020-11-01)

Neoantigen vaccine and neoantigen‐specific cell adoptive transfer therapy in solid tumors: Challenges and future directions
by: Yanwei Shen, et al.
Published: (2022-08-01)

Combining personalized neoantigen vaccination with chemotherapy and anti-PD-1 to treat NSCLC
by: Leung, CSK, et al.
Published: (2022)

Establishment of a novel tumor neoantigen prediction tool for personalized vaccine design
by: Kai Xin, et al.
Published: (2024-12-01)

Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma
by: Martin F Bachmann, et al.
Published: (2022-01-01)

Epidermal Growth Factor Receptor-Targeted Neoantigen Peptide Vaccination for the Treatment of Non-Small Cell Lung Cancer and Glioblastoma
by: Fenge Li, et al.
Published: (2023-09-01)

Personalized neoantigen-based cancer immunotherapy. A literature review
by: Juan Pablo Ortiz-Aguirre, et al.
Published: (2021-05-01)

Neoantigen Cancer Vaccines: Generation, Optimization, and Therapeutic Targeting Strategies
by: Carson R. Reynolds, et al.
Published: (2022-01-01)

Neoantigen cancer vaccine augments anti-CTLA-4 efficacy
by: Erika Salvatori, et al.
Published: (2022-02-01)

Neoantigen‐based vaccines as a promising strategy in cancer immunotherapeutics
by: Anita G. Koshy, et al.
Published: (2021-06-01)

Preventive Cancer Vaccine Based on Neoantigens Gets Put to the Test
by: Alla Katsnelson
Published: (2021-08-01)

Artificial intelligence applied in neoantigen identification facilitates personalized cancer immunotherapy
by: Yu Cai, et al.
Published: (2023-01-01)

SG-APSIC1146: Reducing bacterial contamination in the dental unit waterline (DUWL) in dental clinics
by: Lily Lang, et al.
Published: (2023-02-01)

Development of neoantigens: from identification in cancer cells to application in cancer vaccines
by: Nasim Ebrahimi, et al.
Published: (2022-07-01)

Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer
by: Jun Wang, et al.
Published: (2023-08-01)

Research progress of neoantigen-based dendritic cell vaccines in pancreatic cancer
by: Xin Zhang, et al.
Published: (2023-01-01)

Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma
by: Tanner M. Johanns, et al.
Published: (2019-04-01)

Usefulness of Docking and Molecular Dynamics in Selecting Tumor Neoantigens to Design Personalized Cancer Vaccines: A Proof of Concept
by: Diego Amaya-Ramirez, et al.
Published: (2023-06-01)